An agreement detailing the division of proceeds between two claimants who brought qui tam suits against Quest Diagnostics International should not have been sealed, the U.S. Court of Appeals for the Third Circuit has ruled.
The circuit said in Fair Laboratory Practices Associates v. Riedel that the district court failed to identify any particularized harm that would result if the settlement agreement were open for public view and discounted the public interest in learning the settlement terms.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
